share_log

Chardan Capital Initiates Coverage On Omega Therapeutics With Buy Rating, Announces Price Target of $12

Chardan Capital Initiates Coverage On Omega Therapeutics With Buy Rating, Announces Price Target of $12

Chardan Capital以买入评级启动对欧米茄疗法的报道,宣布目标股价为12美元
Benzinga Real-time News ·  2022/09/23 05:48

Chardan Capital analyst Keay Nakae initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Buy rating and announces Price Target of $12.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发